Clinical trial
Prospective, Multi-center, Randomized, Single Blinded and Parallel Controlled Clinical Investigation to Assess the Performance, Safety and Benefit of the Wishbone HA Medical Device, a Deproteinized Bovine Bone Material, as a Bone Graft Substitute in the Socket Management Indication Requiring Bone Grafting Procedure Before Implant Placement.
NCT06383377 is registered in ClinicalTrials.gov with Wishbone SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective, Multi-center, Randomized, Single Blinded and Parallel Controlled Clinical Investigation to Assess the Performance, Safety and Benefit of the Wishbone HA Medical Device, a Deproteinized Bovine Bone Material, as a Bone Graft Substitute in the Socket Management Indication Requiring Bone Grafting Procedure Before Implant Placement.
- Lead sponsor
- Wishbone SA
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 26, 2024
- Completion date
- March 31, 2030
- Enrollment
- 96 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
bone regeneration, safety issues